Colorcon, Inc. Introduces Opadry EC, A New Film Coating For The Modulation Of Drug Release From Multiparticulate Oral Dosages
Harleysville, Pennsylvania, USA, 13th April 2016, Colorcon Inc. announces the introduction of a new film coating system Opadry® EC, Ethylcellulose Organic Coating System designed for multiparticulate dosages. Colorcon continues to see market growth in multiparticulate dosage forms, especially for geriatric and pediatric populations, and Opadry EC provides a fully formulated solvent coating option that enables a range of release profiles for these specialist dosage forms.
According to Pankaj Rege, General Manager, Manufactured Excipients, at Colorcon Inc. “The base polymer for this system, ethylcellulose, is widely used in the pharmaceutical industry as an insoluble barrier membrane coating; this provides extended release profiles and taste-mask options for granules and orally-disintegrating tablet (ODT) dosages. This innovative addition to our portfolio of coatings expands the tools available for modifying drug release profiles. As a ready-to-use system, Opadry EC means cost effective and consistent coating performance, and helps to reduce potential errors that may occur during raw material handling and manufacturing.”
Colorcon supports faster and simpler formulation development using Opadry EC by providing customers with access to comprehensive applications knowledge and technical support. With reduced preparation steps and less operator handling, Opadry EC simplifies the coating process and reduces risk of production batch failures.
This latest innovation clearly demonstrates Colorcon’s leadership in bringing to market film coating systems with enhanced functionality along with improved convenience, manufacturing efficiency and dependable performance for the pharmaceutical industry.
Company Information
Colorcon is a world leader in the development, supply and technical support of specialty excipients: formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our extensive application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 9 manufacturing facilities, 19 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.
According to Pankaj Rege, General Manager, Manufactured Excipients, at Colorcon Inc. “The base polymer for this system, ethylcellulose, is widely used in the pharmaceutical industry as an insoluble barrier membrane coating; this provides extended release profiles and taste-mask options for granules and orally-disintegrating tablet (ODT) dosages. This innovative addition to our portfolio of coatings expands the tools available for modifying drug release profiles. As a ready-to-use system, Opadry EC means cost effective and consistent coating performance, and helps to reduce potential errors that may occur during raw material handling and manufacturing.”
Colorcon supports faster and simpler formulation development using Opadry EC by providing customers with access to comprehensive applications knowledge and technical support. With reduced preparation steps and less operator handling, Opadry EC simplifies the coating process and reduces risk of production batch failures.
This latest innovation clearly demonstrates Colorcon’s leadership in bringing to market film coating systems with enhanced functionality along with improved convenience, manufacturing efficiency and dependable performance for the pharmaceutical industry.
Company Information
Colorcon is a world leader in the development, supply and technical support of specialty excipients: formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our extensive application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 9 manufacturing facilities, 19 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.